Press Releases

Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening

Mar 21, 2023 - Press Releases

  Toronto, Ontario – March 20, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that the US Patent Office has granted a patent for its AI-powered technology (United States Patent Application Number: 16/892,369) for […]

Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis

Mar 15, 2023 - Press Releases

  Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix’s screening to identify impairment takes less than 30 seconds The mobile application, powered by AI algorithms currently being utilized in Safe Entry will be accompanied by a “mini” multi-spectral imaging camera resulting in a portable non-invasive impairment detection […]

Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia

Mar 8, 2023 - Press Releases

The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix’s Safe Entry for regulatory approval listed as a ‘Medical Device’   Medical device classification allows Predictmedix to commercialize Safe Entry at scale in Indonesia   Third-party clinical validation yet another milestone for Predictmedix’s AI-Powered screening technology   Toronto, Ontario, March 8, 2023 – […]

Predictmedix Announces a Purchase Order for Safe Entry’s Fit for Duty Screening in the Defence Sector

Mar 6, 2023 - Press Releases

DefSpace, a global platform for Defence, Space and Aerospace will lease four Safe Entry Stations over four-year term primarily utilizing Safe Entry’s impairment detection screening   Each of the four Safe Entry Station’s to generate $2500 per month in recurring revenue for an initial four-year term, approximating a total of $500,000   The Global workplace […]

Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare

Feb 15, 2023 - Press Releases

Toronto, Ontario, February 15, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced pivotal clinical validation data from one of the largest Government hospital groups in India for the company’s AI-powered Safe Entry Stations. […]

Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange

Feb 13, 2023 - Press Releases

Toronto, Ontario, February 13, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announces that it has closed a non-brokered private placement for total gross proceeds of $612,500. The Company has issued 12,250,000 units (the “Units”) […]

Predictmedix Provides Corporate Update on Key Technology Milestones and Commercialization Outlook for 2023

Jan 16, 2023 - Press Releases

Toronto, Ontario, January 16, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced a corporate update providing key technology milestones and commercialization outlook for the 2023 calendar year. “Since the beginning of 2022, Safe Entry […]

Predictmedix Deploys Safe Entry’s Fit for Duty Screening at LongArm Engineering

Nov 17, 2022 - Press Releases

LongArm Engineering to implement Safe Entry fitted with Fit for Duty Screening at Odessa Texas facility and new Corporate Office TORONTO, ON / ACCESSWIRE / November 17, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the revenue-generating […]

Predictmedix Provides Business and Technology Development Updates and Closes Final Tranche of Private Placement

Nov 7, 2022 - Press Releases

TORONTO, ON / Preedictmedix / November 7, 2022 / Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE:PMED)(OTCQB:PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), announces that it has closed the final tranche of its non-brokered private placement. Pursuant to the final tranche, the Company has issued 1,600,000 units (the […]

Predictmedix Closes First Tranche of Private Placement

Aug 22, 2022 - Press Releases

Toronto, Ontario, August 22, 2022 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), announces that it has closed the first tranche of a non-brokered private placement (the “First Tranche”). Pursuant to the First Tranche, the Company has […]

Predictmedix and Partners Launch Safe Entry Station as a Comprehensive Fit for Duty Screening Solution at Electra Mining Africa and National Safety Council’s (NSC) Congress & Expo

Aug 8, 2022 - Press Releases

Toronto, ON, August 8, 2022  – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that its Safe Entry Station will be used as a comprehensive Fit for Duty screening solution for workplaces and industries around the world, detecting […]

Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters

Jul 25, 2022 - Press Releases

Toronto, ON, July 25, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced its accuracy rates for identifying Respiration Rate, Heart Rate, and Core Body Temperature as part of its Fit for Work screening solutions for industries […]